Literature DB >> 33608544

Innate immune evasion revealed in a colorectal zebrafish xenograft model.

Vanda Póvoa1, Cátia Rebelo de Almeida1, Mariana Maia-Gil1, Daniel Sobral2, Micaela Domingues1, Mayra Martinez-Lopez1, Miguel de Almeida Fuzeta1, Carlos Silva1, Ana Rita Grosso2, Rita Fior3.   

Abstract

Cancer immunoediting is a dynamic process of crosstalk between tumor cells and the immune system. Herein, we explore the fast zebrafish xenograft model to investigate the innate immune contribution to this process. Using multiple breast and colorectal cancer cell lines and zAvatars, we find that some are cleared (regressors) while others engraft (progressors) in zebrafish xenografts. We focus on two human colorectal cancer cells derived from the same patient that show contrasting engraftment/clearance profiles. Using polyclonal xenografts to mimic intra-tumor heterogeneity, we demonstrate that SW620_progressors can block clearance of SW480_regressors. SW480_regressors recruit macrophages and neutrophils more efficiently than SW620_progressors; SW620_progressors however, modulate macrophages towards a pro-tumoral phenotype. Genetic and chemical suppression of myeloid cells indicates that macrophages and neutrophils play a crucial role in clearance. Single-cell-transcriptome analysis shows a fast subclonal selection, with clearance of regressor subclones associated with IFN/Notch signaling and escaper-expanded subclones with enrichment of IL10 pathway. Overall, our work opens the possibility of using zebrafish xenografts as living biomarkers of the tumor microenvironment.

Entities:  

Year:  2021        PMID: 33608544     DOI: 10.1038/s41467-021-21421-y

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  46 in total

1.  Origins of tumor-associated macrophages and neutrophils.

Authors:  Virna Cortez-Retamozo; Martin Etzrodt; Andita Newton; Philipp J Rauch; Aleksey Chudnovskiy; Cedric Berger; Russell J H Ryan; Yoshiko Iwamoto; Brett Marinelli; Rostic Gorbatov; Reza Forghani; Tatiana I Novobrantseva; Victor Koteliansky; Jose-Luiz Figueiredo; John W Chen; Daniel G Anderson; Matthias Nahrendorf; Filip K Swirski; Ralph Weissleder; Mikael J Pittet
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

2.  Macrophage-Dependent Cytoplasmic Transfer during Melanoma Invasion In Vivo.

Authors:  Minna Roh-Johnson; Arish N Shah; Jason A Stonick; Kumud R Poudel; Julia Kargl; Grace H Yang; Julie di Martino; Rafael E Hernandez; Charles E Gast; Luai R Zarour; Susumu Antoku; A McGarry Houghton; Jose Javier Bravo-Cordero; Melissa H Wong; John Condeelis; Cecilia B Moens
Journal:  Dev Cell       Date:  2017-12-04       Impact factor: 12.270

Review 3.  Immunosuppressive cells in tumor immune escape and metastasis.

Authors:  Yang Liu; Xuetao Cao
Journal:  J Mol Med (Berl)       Date:  2015-12-22       Impact factor: 4.599

Review 4.  Cancer and innate immune system interactions: translational potentials for cancer immunotherapy.

Authors:  Yanan Liu; Gang Zeng
Journal:  J Immunother       Date:  2012-05       Impact factor: 4.456

5.  The prognostic landscape of genes and infiltrating immune cells across human cancers.

Authors:  Andrew J Gentles; Aaron M Newman; Chih Long Liu; Scott V Bratman; Weiguo Feng; Dongkyoon Kim; Viswam S Nair; Yue Xu; Amanda Khuong; Chuong D Hoang; Maximilian Diehn; Robert B West; Sylvia K Plevritis; Ash A Alizadeh
Journal:  Nat Med       Date:  2015-07-20       Impact factor: 53.440

Review 6.  Innate and adaptive immune cells in the tumor microenvironment.

Authors:  Thomas F Gajewski; Hans Schreiber; Yang-Xin Fu
Journal:  Nat Immunol       Date:  2013-10       Impact factor: 25.606

Review 7.  Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion.

Authors:  Robert D Schreiber; Lloyd J Old; Mark J Smyth
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

8.  Heterogeneous tumor subpopulations cooperate to drive invasion.

Authors:  Anna Chapman; Laura Fernandez del Ama; Jennifer Ferguson; Jivko Kamarashev; Claudia Wellbrock; Adam Hurlstone
Journal:  Cell Rep       Date:  2014-07-24       Impact factor: 9.423

Review 9.  Targeting macrophages: therapeutic approaches in cancer.

Authors:  Luca Cassetta; Jeffrey W Pollard
Journal:  Nat Rev Drug Discov       Date:  2018-10-26       Impact factor: 84.694

Review 10.  Zebrafish cancer: the state of the art and the path forward.

Authors:  Richard White; Kristin Rose; Leonard Zon
Journal:  Nat Rev Cancer       Date:  2013-09       Impact factor: 60.716

View more
  12 in total

1.  In vivo 3D profiling of site-specific human cancer cell morphotypes in zebrafish.

Authors:  Dagan Segal; Hanieh Mazloom-Farsibaf; Bo-Jui Chang; Philippe Roudot; Divya Rajendran; Stephan Daetwyler; Reto Fiolka; Mikako Warren; James F Amatruda; Gaudenz Danuser
Journal:  J Cell Biol       Date:  2022-09-26       Impact factor: 8.077

2.  Zebrafish Xenograft Model for Studying Pancreatic Cancer-Instructed Innate Immune Microenvironment.

Authors:  Xue Wang; Wei Li; Haowei Jiang; Cui Ma; Mengling Huang; Xiaona Wei; Wei Wang; Lili Jing
Journal:  Int J Mol Sci       Date:  2022-06-09       Impact factor: 6.208

3.  Identifying drivers of breast cancer metastasis in progressively invasive subpopulations of zebrafish-xenografted MDA-MB-231.

Authors:  Jerry Xiao; Joseph R McGill; Apsra Nasir; Alexander Lekan; Bailey Johnson; Devan J Wilkins; Gray W Pearson; Kandice Tanner; Hani Goodarzi; Eric Glasgow; Richard Schlegel; Seema Agarwal
Journal:  Mol Biomed       Date:  2022-05-26

Review 4.  Beyond Genetics: Metastasis as an Adaptive Response in Breast Cancer.

Authors:  Federica Ruscitto; Niccolò Roda; Chiara Priami; Enrica Migliaccio; Pier Giuseppe Pelicci
Journal:  Int J Mol Sci       Date:  2022-06-03       Impact factor: 6.208

Review 5.  Natural killer cells: a promising immunotherapy for cancer.

Authors:  Junfeng Chu; Fengcai Gao; Meimei Yan; Shuang Zhao; Zheng Yan; Bian Shi; Yanyan Liu
Journal:  J Transl Med       Date:  2022-05-23       Impact factor: 8.440

6.  Macrophage-Mediated Melanoma Reduction after HP-NAP Treatment in a Zebrafish Xenograft Model.

Authors:  Gaia Codolo; Nicola Facchinello; Nicole Papa; Ambra Bertocco; Sara Coletta; Clara Benna; Luigi Dall'Olmo; Simone Mocellin; Natascia Tiso; Marina de Bernard
Journal:  Int J Mol Sci       Date:  2022-01-31       Impact factor: 5.923

7.  Zebrafish xenograft model for studying mechanism and treatment of non-small cell lung cancer brain metastasis.

Authors:  Ruo-Yue Fan; Jia-Qi Wu; Yu-Yang Liu; Xiang-Yu Liu; Si-Tong Qian; Chong-Yong Li; Ping Wei; Zhe Song; Ming-Fang He
Journal:  J Exp Clin Cancer Res       Date:  2021-11-20

8.  Bioluminescent Zebrafish Transplantation Model for Drug Discovery.

Authors:  Martina Hason; Jovana Jovicic; Ivana Vonkova; Milan Bojic; Theresa Simon-Vermot; Richard M White; Petr Bartunek
Journal:  Front Pharmacol       Date:  2022-04-27       Impact factor: 5.988

9.  Dietary Inclusion of Seabuckthorn (Hippophae rhamnoides) Mitigates Foodborne Enteritis in Zebrafish Through the Gut-Liver Immune Axis.

Authors:  Ming Li; Xuyang Zhao; Jiayuan Xie; Xinyu Tong; Junwei Shan; Mijuan Shi; Guangxin Wang; Weidong Ye; Yuhang Liu; Bruno Hamish Unger; Yingyin Cheng; Wanting Zhang; Nan Wu; Xiao-Qin Xia
Journal:  Front Physiol       Date:  2022-04-06       Impact factor: 4.755

Review 10.  Preclinical models as patients' avatars for precision medicine in colorectal cancer: past and future challenges.

Authors:  Erika Durinikova; Kristi Buzo; Sabrina Arena
Journal:  J Exp Clin Cancer Res       Date:  2021-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.